Cofoe Cost Of Revenue from 2010 to 2024

301087 Stock   38.10  0.33  0.87%   
Cofoe Medical's Cost Of Revenue is increasing over the years with slightly volatile fluctuation. Cost Of Revenue is expected to dwindle to about 1.5 B. From 2010 to 2024 Cofoe Medical Cost Of Revenue quarterly data regression line had arithmetic mean of  1,106,308,480 and r-squared of  0.64. View All Fundamentals
 
Cost Of Revenue  
First Reported
2010-12-31
Previous Quarter
1.6 B
Current Value
1.5 B
Quarterly Volatility
320 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cofoe Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cofoe Medical's main balance sheet or income statement drivers, such as Tax Provision of 38.6 M, Net Interest Income of 19.8 M or Interest Income of 24.4 M, as well as many indicators such as . Cofoe financial statements analysis is a perfect complement when working with Cofoe Medical Valuation or Volatility modules.
  
This module can also supplement various Cofoe Medical Technical models . Check out the analysis of Cofoe Medical Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Cofoe Stock

Cofoe Medical financial ratios help investors to determine whether Cofoe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cofoe with respect to the benefits of owning Cofoe Medical security.